Hui Liu1, Hang Fu1, Ying-Kun Guo1, Zhi-Gang Yang2, Hua-Yan Xu1, Xiao Shuai3, Rong Xu1, Zhen-Lin Li2, Chun-Chao Xia2, Yong He4, Xiao-Yue Zhou5. 1. Department of Radiology, Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, China. 2. Department of Radiology, National Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. 3. Department of Hematology, West China Hospital, Sichuan University, Chengdu 610041, China. 4. Department of Cardiology, West China Hospital, Sichuan University, Chengdu 610041, China. 5. MR Collaboration, Siemens Healthcare Ltd., Shanghai 201318, China.
Abstract
BACKGROUND: Early detection of right ventricular (RV) dysfunction is vital for determining the prognosis of light-chain amyloidosis (AL) patients. While few studies focused on RV deformation due to the limitation of research methods. The aim of this study was to determine the prognostic significance of RV myocardial strain in AL patients assessed by cardiac magnetic resonance (CMR) tissue tracking. METHODS: Sixty-four AL patients (28 females and 36 males, mean age 58±12.8 years old; range 25-81 years old) were enrolled from 1 October 2014 through 31 March 2017 and compared with 20 age- and sex-matched controls. Fifty-one AL patients met the criteria for cardiac amyloidosis (CA). Deformation parameters of both RV and left ventricle (LV) were measured by the CMR tissue tracking technique including myocardial global radial peak strain (GRPS), global circumferential peak strain (GCPS), and global longitudinal peak strain (GLPS). The follow-up time was 20 months or until the occurrence of death. RESULTS: Thirty-two (50%) had preserved RV ejection fraction (RVEF ≥45%). AL patients had significantly lower RV-GRPS (20.3±2.12 vs. 31.31±7.61), GCPS (-2.12±0.88 vs. -13.71±2.53), and GLPS (-5.33±0.64 vs. -14.239±2.99) than controls even RVEF remain preserved (all P<0.001). Compared with controls and patients without CA, RV-GRPS (12.26±1.26 vs. 29.72±3.54, P<0.001) and RV-GLPS (-3.78±2.25 vs. -5.66±2.08, P<0.05) were significantly lower in patients with CA. Cox multivariate analyses demonstrated that RV-GRPS [hazard ratio (HR) =0.93, 95% CI: 0.88-0.98, P=0.007] and Mayo stage were (HR =3.11, 95% CI: 1.30-7.41, P=0.01) predictors of mortality in AL patients. CONCLUSIONS: CMR tissue tracking is a feasible and highly reproducible technique for the analysis of RV deformation and could aid in the early diagnosis of RV involvement in AL patients. RV-GRPS of RV strain and Mayo stage provides prognostic information about mortality in AL patients. 2020 Cardiovascular Diagnosis and Therapy. All rights reserved.
BACKGROUND: Early detection of right ventricular (RV) dysfunction is vital for determining the prognosis of light-chain amyloidosis (AL) patients. While few studies focused on RV deformation due to the limitation of research methods. The aim of this study was to determine the prognostic significance of RV myocardial strain in AL patients assessed by cardiac magnetic resonance (CMR) tissue tracking. METHODS: Sixty-four AL patients (28 females and 36 males, mean age 58±12.8 years old; range 25-81 years old) were enrolled from 1 October 2014 through 31 March 2017 and compared with 20 age- and sex-matched controls. Fifty-one AL patients met the criteria for cardiac amyloidosis (CA). Deformation parameters of both RV and left ventricle (LV) were measured by the CMR tissue tracking technique including myocardial global radial peak strain (GRPS), global circumferential peak strain (GCPS), and global longitudinal peak strain (GLPS). The follow-up time was 20 months or until the occurrence of death. RESULTS: Thirty-two (50%) had preserved RV ejection fraction (RVEF ≥45%). AL patients had significantly lower RV-GRPS (20.3±2.12 vs. 31.31±7.61), GCPS (-2.12±0.88 vs. -13.71±2.53), and GLPS (-5.33±0.64 vs. -14.239±2.99) than controls even RVEF remain preserved (all P<0.001). Compared with controls and patients without CA, RV-GRPS (12.26±1.26 vs. 29.72±3.54, P<0.001) and RV-GLPS (-3.78±2.25 vs. -5.66±2.08, P<0.05) were significantly lower in patients with CA. Cox multivariate analyses demonstrated that RV-GRPS [hazard ratio (HR) =0.93, 95% CI: 0.88-0.98, P=0.007] and Mayo stage were (HR =3.11, 95% CI: 1.30-7.41, P=0.01) predictors of mortality in AL patients. CONCLUSIONS: CMR tissue tracking is a feasible and highly reproducible technique for the analysis of RV deformation and could aid in the early diagnosis of RV involvement in AL patients. RV-GRPS of RV strain and Mayo stage provides prognostic information about mortality in AL patients. 2020 Cardiovascular Diagnosis and Therapy. All rights reserved.
Entities:
Keywords:
Cardiac magnetic resonance (CMR); cardiac amyloidosis (CA); right ventricular (RV); tissue tracking
Authors: Morie A Gertz; Ray Comenzo; Rodney H Falk; Jean Paul Fermand; Bouke P Hazenberg; Philip N Hawkins; Giampaolo Merlini; Philippe Moreau; Pierre Ronco; Vaishali Sanchorawala; Orhan Sezer; Alan Solomon; Giles Grateau Journal: Am J Hematol Date: 2005-08 Impact factor: 10.047
Authors: Marco van Kessel; David Seaton; Jonathan Chan; Akira Yamada; Fiona Kermeen; Christian Hamilton-Craig; Thomas Butler; Surendran Sabapathy; Norman Morris Journal: Int J Cardiovasc Imaging Date: 2016-03-01 Impact factor: 2.357
Authors: Stefan Aschauer; Andreas A Kammerlander; Caroline Zotter-Tufaro; Robin Ristl; Stefan Pfaffenberger; Alina Bachmann; Franz Duca; Beatrice A Marzluf; Diana Bonderman; Julia Mascherbauer Journal: Eur J Heart Fail Date: 2015-10-09 Impact factor: 15.534
Authors: Aleksander Kempny; Rodrigo Fernández-Jiménez; Stefan Orwat; Pia Schuler; Alexander C Bunck; David Maintz; Helmut Baumgartner; Gerhard-Paul Diller Journal: J Cardiovasc Magn Reson Date: 2012-05-31 Impact factor: 5.364
Authors: Sanjay M Banypersad; Daniel M Sado; Andrew S Flett; Simon D J Gibbs; Jennifer H Pinney; Viviana Maestrini; Andrew T Cox; Marianna Fontana; Carol J Whelan; Ashutosh D Wechalekar; Philip N Hawkins; James C Moon Journal: Circ Cardiovasc Imaging Date: 2012-11-28 Impact factor: 7.792